Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Plos One|July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcomaPeter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Cancers|August 14, 2025
Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular CarcinomaEmma J Hoelzen, Hanna S Radomska, Samuel K Kulp, et al.
EMBO Molecular Medicine|January 14, 2020
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitorSophia G Liva, Yu-Chou Tseng, Anees M Dauki, et al.
Molecular Cancer Therapeutics|July 19, 2018
Phyllanthusmin Derivatives Induce Apoptosis and Reduce Tumor Burden in High-Grade Serous Ovarian Cancer by Late-Stage Autophagy InhibitionAlexandria N Young, Denisse Herrera, Andrew C Huntsman, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2021
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignanciesKatharine A Collier, Hugo Valencia, Herbert Newton, et al.
Cancer Research|October 6, 2017
Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate CancerSuriyan Ponnusamy, Christopher C Coss, Thirumagal Thiyagarajan, et al.
Frontiers in Oncology|May 16, 2022
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast CancerJharna Datta, Natalie Willingham, Jasmine M Manouchehri, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonistsAdeoluwa A Adeluola, Hanna S Radomska, Tyler A Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 27, 2024
<b>The elucidation of species-specific receptor pharmacology: a case study using subtype selective </b>Adeoluwa A Adeluola, Hanna S Radomska, Tyler A Wilson, et al.
Cancer Immunology Research|January 6, 2019
SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune EvasionChunwan Lu, Dafeng Yang, John D Klement, et al.
Pageof 7